Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, IT services specialist Syntel (NASDAQ: SYNT ) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at Syntel and see what CAPS investors are saying about the stock right now.
Syntel facts
Headquarters (founded)
Troy, Mich. (1980)
Market Cap
$2.74 billion
Industry
Information technology services
Trailing-12-Month Revenue
$742.3 million
Hot Dow Dividend Companies To Watch In Right Now: Impala Platinum Holdings Ltd (IMPUY.PK)
Impala Platinum Holdings Limited (Implats) is a producer of platinum group metals (PGMs) and associated base metals. Implats has operations on the PGM-bearing orebodies of the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe. PGMs include platinum, and the associated by-products, palladium, rhodium, ruthenium, iridium and gold usually occur in association with nickel and copper. As of June 30, 2012, the Company�� holdings in various mining and exploration activities included Impala Platinum Limited (100%), which includes PGM mining, processing and refining; Impala Refining Services Limited (100%), which is engaged in purchase of concentrate and/or smelter matte; Impala Chrome (Pty) Limited (100%) and Makgomo Chrome (Pty) Limited (50%), which are engaged in purchase of chrome in tailings, and Zimplats Holdings Limited (86.9%), Afplats (Pty) Limited (74%), Marula Platinum (Pty) Limited (73%), Mimosa Investments Limited (50%) and Two Rivers Platinum (Pty) Limited (45%), which are engaged in PGM mining.
Impala Platinum
Impala Platinum, Implats��primary operational unit, has operations situated on the Impala lease area on the western limb of the Bushveld Complex near Rustenburg in South Africa, and in Springs east of Johannesburg. Impala holds contiguous mining rights and prospecting rights for a total area of 260 square kilometres. Operations comprise 14 operational shaft systems, five of which have underground decline systems.
Zimplats Holdings Limited
Zimplats Holdings Limited (Zimplats) is 87% owned by Implats and is located on the Hartley Geological Complex on the Zimbabwean Great Dyke south-west of Harare. Zimplats operates three underground mines and a concentrator at Ngezi. The Selous Metallurgical Complex (SMC), located some 77 kilometer north of the mine, comprises a concentrator and a smelter. The Company also owns the Hartley Platinum Mine situated at the SMC, which is under care and maintenance.
Marula Platin! um Limited
Marula Platinum Limited (Marula) is 73% owned by Implats. Marula is located in the Limpopo Province, some 50 kilometres north of Burgersfort. The operation consists of two on-reef decline shafts, one off-reef conventional decline and a concentrator plant.
Mimosa
Mimosa is wholly owned by Mimosa Investments Limited, a Mauritius-based company jointly held by Implats and Aquarius Platinum Limited (Aquarius) in a 50:50 joint-venture. Mimosa is located on the Wedza Geological Complex on the Zimbabwean Great Dyke east of Bulawayo. The operation comprises a shallow underground mine, accessed by a decline shaft, and a concentrator.
The Two Rivers Platinum Mine
The Two Rivers Platinum Mine (Two Rivers) is a joint venture between African Rainbow Minerals (ARM) (55%) and Impala Platinum Holdings Limited (Implats) (45%). The operation is situated on the farm Dwarsrivier on the southern part of the eastern limb of the Bushveld Igneous Complex in Mpumalanga, South Africa. The operation consists of two on-reef decline shafts and a concentrator.
Impala Refining Services (IRS)
IRS products include flotation concentrates from Marula, Mimosa and Two Rivers, as well as Aquarius��Marikana, Everest mine and Blue Ridge mines (on care and maintenance) and Eastern Platinum�� Crocodile River mine; furnace matte from Zimplats; spent autocatalysts from A-1 Specialised Services and Supplies Inc. for recycling, and selected base metal residues and other secondary materials.
Advisors' Opinion:- [By Zacks Investment Research]
It is hard to find a good play in the Zacks Industry of mining non-ferrous metals, as the industry currently has a rank of 247 out of 261. In fact, in our five mining industries, there are only two No. 1-Ranked stocks: Brigus Gold (BRD) and Impala (IMPUY.PK). Both of these are in struggling industries, but they have proven to be best-in-class thanks to improving earnings estimates. Plus, both have seen their ranks surge from holds (or worse) up to strong buy territory, suggesting either of these names might be better picks than the struggling SCCO at this time.
5 Best Information Technology Stocks To Watch For 2014: Informatica Corporation (INFA)
Informatica Corporation provides enterprise data integration and data quality software and services worldwide. Its software solutions include a set of technologies that enable various enterprise-wide data integration initiatives. The company offers PowerCenter, which integrates data virtually from business systems in various formats and delivers that data throughout the enterprise; PowerExchange that enables IT organizations to access the sources of enterprise data without having to develop custom data access programs; and Informatica Data Services for finding, integrating, and managing data across the enterprise. It also provides Data Quality, which delivers data quality to stakeholders, projects, and data domains; Master Data Management that provides consolidated business-critical data; and B2B Data Exchange software for multi-enterprise data integration. In addition, the company offers application information lifecycle management products to manage various phases of the data lifecycle, from development and testing to archiving and retirement; complex event processing to detect, correlate, analyze, and respond to data-driven events; Ultra Messaging products, which enables ultra low latency messaging; and Cloud that delivers purpose-built data integration cloud applications to allow business users to integrate data across cloud-based applications, and on-premise systems and databases. Further, it offers product-related customer support, consulting, and education services. Informatica Corporation serves aerospace, automotive, energy and utilities, entertainment/media, financial services, healthcare/life sciences, high technology, insurance, manufacturing, public sector, retail, services, telecommunications, and travel/transportation industries through its direct sales force, as well as through systems integrators, resellers, distributors, and original equipment manufacturer partners. The company was founded in 1993 and is headquartered in Red wood City, California.
Advisors' Opinion:- [By Garrett Cook]
In trading on Friday, technology shares were relative laggards, down on the day by about 0.80 percent. Top decliners in the sector included Silicon Laboratories (NASDAQ: SLAB), down 13.7 percent, and Informatica (NASDAQ: INFA), off 13.4 percent.
5 Best Information Technology Stocks To Watch For 2014: AIA Group Ltd (AAIGF.PK)
AIA Group Limited is an investment holding company. The Company and its subsidiaries are engaged in provision of products and services to individuals and businesses for their insurance, protection, savings, investment and retirement needs. The Company operates life insurance business, providing life, pensions, and accident and health products to customers in its local market, and distributes related investment and other financial services products. The Company serves more than 100,000 corporate clients with more than 13 million group insurance scheme members. It has operations in Hong Kong, Thailand, Singapore, Malaysia, China, Korea, the Philippines, Indonesia, Vietnam, India, Australia, Taiwan, New Zealand, Macau and Brunei. As of November 30, 2012, its subsidiaries included American International Assurance Company, Limited (AIA Co.), American International Assurance Company (Bermuda) Limited (AIA-B), AIA Australia Limited and PT AIA Financial, among others. Advisors' Opinion:- [By Holly LaFon]
Berkowitz�� top holdings continue to be: American International Group Inc. (AIG), AIA Group Ltd. (AAIGF.PK), Sears Holdings Corp. (SHLD), Berkshire Hathaway Inc. (BRK.B) and Brookfield Asset Management Inc. (BAM).
5 Best Information Technology Stocks To Watch For 2014: Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp., incorporated in 1993, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threatening genetic conditions. Its lead program, SBC-102, recombinant human lysosomal acid lipase (LAL), is its advanced pipeline program in clinical development for LAL Deficiency. This enzyme is responsible for the metabolism of cholesteryl esters and triglycerides that are delivered to lysosomes by a variety of routes, including low-density lipoprotein receptor mediated endocytosis. On November 2, 2012, Trimeris, Inc. merged with Synageva BioPharma Corp.
SBC-102 is produced by recombinant deoxyribonucleic acid (DNA) technology in egg white using its protein manufacturing platform. The Company has initiated natural history studies in approximately 20 countries. In addition to SBC-102, it is progressing protein therapeutic programs for other rare diseases, which are at different stages of preclinical development. These include two enzyme replacement therapies for other lysosomal storage disorders and two programs for other rare life-threatening conditions. As of December 31, 2011, its product candidate pipeline included SBC-102, SBC-103, SBC-104, SBC-105 and SBC-106.
SBC-104 is an extracellular protein that targets a severe, rare genetic condition. SBC-105 is an enzyme replacement therapy being developed to treat a severe, rare metabolic disorder. SBC-106 is a protein therapy that targets a severe and rare genetic condition.
Advisors' Opinion:- [By Garrett Cook]
Shares of Synageva BioPharma (NASDAQ: GEVA) were down 14.42 percent to $89.69 after the company reported that Phase 3 study met primary endpoint and six secondary endpoints across multiple disease-related abnormalities. Citigroup initiated coverage on Synageva BioPharma with a Neutral rating.
- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
No comments:
Post a Comment